Bacterial Expression of Biologically Active High Molecular Weight Kininogen Light Chain

Summary

Human high molecular weight kininogen (HK), a single chain plasma glycoprotein, serves as a cofactor in the contact system of blood coagulation. After cleavage by human plasma kallikrein, the nonapeptide bradykinin is released. The HK light chain (LC) contains coagulant activity, which requires both the ability to bind the contact system zymogens, prekallikrein and factor XI, and the ability to interact with negatively charged surfaces. Since bacterial expression might not be successful if carbohydrate was required for activity, we evaluated that possibility by incubating plasma HK with endoglycosydase F. Although the procedure removed detectable N-linked carbohydrate, no change in specific activity occurred. We then developed a bacterial expression system to produce recombinant HK LC. The cDNA coding for the HK LC was prepared by polymerase chain reaction (PCR), digested with restriction enzymes EcoRI and PstI, and introduced into the bacterial expression vector pKK223-3. E. coli harboring this recombinant plasmid (pSKl) expressed HK LC upon induction with isopropylthio-galactoside (IPTG). The recombinant protein (27 kDa), when transferred onto a PVDF membrane, was recognized by monospecific polyclonal anti-HK LC-antibodies. The recombinant HK LC was purified by heparin agarose affinity chromatography to homogeneity and found to have a specific activity of 28 coagulant units per mg protein, similar to the specific activity of the LC derived by proteolytic digestion of human plasma HK. We conclude: 1) The HK LC synthesized in bacteria is biologically active, and 2) the 40% carbohydrate content of the HK LC is not required for its cofactor activity.

• References

• 1 Kitamura N, Kitagawa H, Fukushima D, Takagaki Y, Miyata T, Nakanishi S. Structural organization of the human kininogen gene and a model for its evolution. J Biol Chem 1985; 260: 8610
• 2 Schmaier AH, Zuckerberg A, Silverman C, Kuchibhotla J, Tuszynski G, Colman RW. High molecular weight kininogen - a secreted platelet coagulant protein. J Clin Invest 1983; 71: 1477
• 3 Bouma BN, Kerbiriou DM, Vluswijk RAA, Griffin JH. Immunochemical studies of prekallikrein, kallikrein, high molecular weight kininogen in normal and deficient plasma and in normal plasma after cold dependent activation. J Lab Clin Med 1980; 96: 693
• 4 Proud D, Pierce JV, Pisano JJ. Radioimmunoassay of human high molecular weight kininogen in normal and deficient plasma. J Lab Clin Med 1980; 95: 563
• 5 Mandle Jr R, Colman RW, Kaplan AP. Identification of prekallikrein and high molecular weight kininogen as a complex in human plasma. Proc Natl Acad Sci USA 1976; 73: 4179
• 6 Scott CF, Colman RW. Function and immunochemistry of prekallikrein. High molecular weight kininogen complex in plasma. J Clin Invest 1980; 65: 413
• 7 Saito H, Ratnoff OD, Marshall JS, Pensky J. Partial purification of plasma thromboplastin antecedent (factor XI) and its activation by trypsin. J Clin Invest 1973; 52: 850
• 8 Scott CF, Silver LD, Schapira M, Colman RW. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity: Evidence that this molecule exists as a procofactor. J Clin Invest 1984; 73: 954
• 9 Tait JF, Fujikawa K. Primary structure requirements for the binding of human high molecular weight kininogen to plasma prekallikrein and factor XI. J Biol Chem 1987; 262: 11651
• 10 Sugo T, Ikara N, Kato H, Iwanaga S, Fujii S. Functional sites of bovine high molecular weight kininogen as a cofactor in kaolin-mediated activation of factor XII (Hageman factor). Biochemistry 1980; 19: 3215
• 11 Thompson RE, Mandle Jr R, Kaplan AP. Association of factor XI and high molecular weight kininogen in human plasma. J Clin Invest 1977; 60: 1376
• 12 van Iwaarden F, Bouma BN. Role of high molecular weight kininogen in contact activation. Semin Thromb Hemostas 1987; 13: 15
• 13 Chung DW, Fujikawa K, McMullen BA, Davie EW. Human plas-maprekallikrein, a zymogen to a serine protease that contains four tandem repeats. Biochemistry 1986; 25: 2410
• 14 Fujikawa K, Chung DW, Hendrickson LE, Davie EW. Amino acid sequence of human factor XI, a blood coagulation factor with four tandem repeats that are highly homologous with plasma prekallikrein. Biochemistry 1986; 25: 2417
• 15 Heimark RL, Kurachi K, Fujikawa K, Davie EW. Surfact activation of blood coagulation, fibrinolysis and kinin formation. Nature 1980; 286: 456
• 16 Matheson RT, Miller DR, Lacombe MJ, Han YN, Iwanaga S, Kato H, Wuepper KD. Flaujeac factor deficiency. Reconstitution with highly purified bovine high molecular-weight kininogen and delineation of a new permeability-enhancing peptide released by plasma kallikrein from bovine high molecular-weight kininogen. J Clin Invest 1976; 58: 1395
• 17 Waldmann R, Scicli AG, McGregor RK, Carretero OA, Abraham JP, Kato H, Han YV, Iwanaga S. Effect of bovine high molecular weight kininogen and its fragments on Fitzgerald trait plasma. Thromb Res 1976; 8: 785
• 18 Colman RW, Bagdasarian A, Talamo RC, Scott CF, Seavey M, Guimaraes JA, Pierce JV, Kaplan AP. Williams trait: Human kininogen deficiency both diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways. J Clin Invest 1975; 56: 1650
• 19 Schmaier AH, Schutsky D, Farber A, Silver LD, Bradford HN, Colman RW. Determination of the bifunctional properties of high molecular weight kininogen by studies with monoclonal antibodies directed to each of its chains. J Biol Chem 1987; 262: 1405
• 20 DeLa Cadena RA, Colman RW. Primary structural feature recognized by a monoclonal antibody neutralizing the coagulant activity by a binding of high molecular weight kininogen (HK) to anionic surfaces. Blood 1989; 74: 292 A
• 21 Takagaki Y, Kitamura N, Nakanishi S. Cloning and sequence analysis of cDNAs for human high molecular weight and low molecular weight kininogens. J Biol Chem 1985; 260: 8601
• 22 Mullis KB, Faloona F, Scharf SJ, Saiki RK, Horn GT, Ehrlich HA. Cold Spring Harbor Symp Quant Biol 1975; 51: 263
• 23 Weislander L. A simple method to recover intact molecular weight RNA and DNA after electrophoretic separation in low gelling temperature agarose gels. Anal Biochem 1979; 98: 305
• 24 Birnboim HC, Doly J. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleid Acid Res 1979; 7: 1513
• 25 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T 4. Nature 1970; 227: 680
• 26 Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350
• 27 Kerbirou DM, Griffin JH. Human high molecular weight kininogen: Studies of structure-function relationships and of proteolysis of the molecule occurring during contact activation of plasma. J Biol Chem 1979; 254: 12020
• 28 Scott CF, Liu CY, Colman RW. Human plasma prekallikrein: A rapid high yield method for purification. Eur J Biochem 1979; 100: 77
• 29 Proctor RR, Rapaport SJ. The partial thromboplastin time with kaolin: A simple screening test for the first stage plasma clotting factor deficiencies. Am J Clin Pathol 1961; 36: 212
• 30 Elder JH, Alexander S. Endo-beta-N-acetylglucosaminidase F: Endoglycosidase from Flavobacterium meningosepticum that cleaves both high-mannose and complex glycoproteins. Proc Natl Acad Sci USA 1982; 79: 4540
• 31 O’Shannessy DJ, Voorstad PJ, Quarles RH. Quantitation of glycoproteins on electroblots using the biotin-streptavidin complex. Anal Biochem 1987; 163: 204
• 32 Sanger F, Nicklen S, Coulson AR. DNA sequencing with chainterminating inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463
• 33 Krawczak M, Reiss J, Schmidtke J, Rosier U. Polymerase chain reaction: Replication errors and reliability of gene diagnosis. Nucleic Acid Res 1989; 17: 2197
• 34 Coligan JE, Slayter H. Structure of thrombospondin. J Biol Chem 1984; 259: 3944
• 35 Rosenberg RD, Damus PS. The purification and mechanism of action of human antithrombin-heparin cofactor. J Biol Chem 1973; 248: 6490
• 36 Thompson RE, Mandle Jr R, Kaplan AP. Characterization of human high molecular weight kininogen: Procoagulant activity associated with the light chain of kinin free high molecular weight kininogen. J Exp Med 1978; 147: 488
• 37 Kunapuli SP, Prasad GL, Kumar A. Expression of human angioten-sinogen cDNA in Escherichia coli . J Biol Chem 1987; 262: 7672
• 38 Imai T, Cho T, Takamatsu H, Hori H, Saito M, Matuda T, Hirose H, Murakami K. Synthesis and characterization of human prorenin in Escherichia coli . J Biol Chem 1986; 100: 425
• 39 Sarawathi S, Colman RW. Role of galactose in bovine factor V. J Biol Chem 1975; 250: 8111
• 40 Vermylen J, Donati MB, De Gaetano G, Vertraete M. Aggregation of human platelets by bovine or human factor VIII: Role of carbohydrate side chains. Nature 1973; 244: 167
• 41 Gralnick HR, Williams SB, Rick ME. Role of carbohydrate in multimeric structure of factor VIH/von Willebrand factor protein. Proc Natl Acad Sci USA 1983; 80: 2771
• 42 Morisato DK, Gralnick HR. Selective binding of the factor VIH/von Willebrand factor protein to human platelets. Blood 1980; 55: 9
• 43 Chesney CM, Harper E, Colman RW. Critical role of the carbohydrate side chains of collagen in platelet aggregation. J Clin Invest 1972; 51: 2693